B

BPH Global Ltd
ASX:BP8

Watchlist Manager
BPH Global Ltd
ASX:BP8
Watchlist
Price: 0.002 AUD 33.33%
Market Cap: 5.6m AUD

Profitability Summary

BPH Global Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
BPH Global Ltd

Margins Comparison
BPH Global Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
BPH Global Ltd
ASX:BP8
5.6m AUD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
386.1B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.2B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
163.5B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.6B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.5B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.4B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.7B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.4B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
BPH Global Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
BPH Global Ltd
ASX:BP8
5.6m AUD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
386.1B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.2B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
163.5B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.5B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.4B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.7B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
BPH Global Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate